Search research articles
Contact Us
Filters
Showing results (391-400 of 423) with videos related to
Page
of 43
Sort By:
American Journal of Cancer Research
|
September 11, 2023
Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regions
Yan-Ting Lin, Po-Ting Lin, Chen-Chun Lin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 14, 2012
CIP2A is a predictor of poor prognosis in colon cancer
Hao-Wei Teng, Shung-Haur Yang, Jen-Kou Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 5, 2011
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study
Ya-Hsu Yang, Jen-Kou Lin, Wei-Shone Chen, et al.
International Journal of Colorectal Disease
|
December 4, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer
Kuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
January 10, 2021
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
Kun-Huei Yeh, Tsai-Sheng Yang, Tzu-Chi Hsu, et al.
Scientific Reports
|
July 29, 2021
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
Hung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 24, 2015
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults
Rupak Shivakoti, Parul Christian, Wei-Teng Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2024
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
Akihito Kawazoe, Rui-Hua Xu, Pilar García-Alfonso, et al.
International Journal of Cancer
|
April 14, 2019
RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer
Wei-Chung Cheng, Tsai-Tsen Liao, Chun-Chi Lin, et al.
The Journal of Infectious Diseases
|
December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings
Rupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 423) with videos related to
Sort By:
Page
of 43
American Journal of Cancer Research
|
September 11, 2023
Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regions
Yan-Ting Lin, Po-Ting Lin, Chen-Chun Lin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 14, 2012
CIP2A is a predictor of poor prognosis in colon cancer
Hao-Wei Teng, Shung-Haur Yang, Jen-Kou Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 5, 2011
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study
Ya-Hsu Yang, Jen-Kou Lin, Wei-Shone Chen, et al.
International Journal of Colorectal Disease
|
December 4, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer
Kuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
January 10, 2021
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
Kun-Huei Yeh, Tsai-Sheng Yang, Tzu-Chi Hsu, et al.
Scientific Reports
|
July 29, 2021
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
Hung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 24, 2015
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults
Rupak Shivakoti, Parul Christian, Wei-Teng Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2024
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
Akihito Kawazoe, Rui-Hua Xu, Pilar García-Alfonso, et al.
International Journal of Cancer
|
April 14, 2019
RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer
Wei-Chung Cheng, Tsai-Tsen Liao, Chun-Chi Lin, et al.
The Journal of Infectious Diseases
|
December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings
Rupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Page
of 43